{"id":5292,"date":"2025-06-09T19:53:43","date_gmt":"2025-06-09T16:23:43","guid":{"rendered":"https:\/\/barkathpg.com\/?p=5292"},"modified":"2025-06-09T19:58:59","modified_gmt":"2025-06-09T16:28:59","slug":"5292","status":"publish","type":"post","link":"https:\/\/barkathpg.com\/en\/5292\/","title":{"rendered":"COVID-19, Metabolism & Modern Pharmacy: How a Virus Redefined Blueprint of Future Therapies"},"content":{"rendered":"

Barekat Health & Pharmaceutical Group: <\/strong>When COVID-19 emerged, the general and even medical consensus was that we were facing an acute respiratory illness. However, reality soon surprised us. Patients discharged from intensive care returned with symptoms seemingly unrelated to the lungs: significant weight gain or loss, type 2 diabetes, hair loss, chronic fatigue, muscle pain, mood swings, persistent insomnia, and appetite changes.<\/p>\n

In truth, COVID-19 exerted complex effects on the body, striking the metabolic system\u2014the heart of energy regulation, sugar, fat, hormones, and even mood. This revealed COVID-19 as a “multi-systemic impact virus,” targeting multiple vital systems simultaneously, with consequences persisting for months after infection.<\/p>\n

This report explores a critical and practical question: Why does COVID-19 profoundly transform the body, and how has this forced the pharmaceutical industry to redefine treatments?<\/p>\n

When the Virus Took Command of Nutrition & Energy<\/strong><\/p>\n

Our body depends on precise systems to maintain vital balance: hormones like insulin, glands such as the thyroid, receptors on cells, and enzymes in the liver and kidneys. COVID-19 invades cells bearing ACE2 receptors\u2014from lungs to pancreas to fat cells\u2014not only impairing respiratory function but disrupting fundamental metabolic processes, energy management, sugar and fat regulation, and even mood.<\/p>\n

One major cause of prolonged fatigue and malaise after COVID is mitochondrial dysfunction\u2014mitochondria being the cell\u2019s energy factories. Patients experienced energy deficits and overeating due to misinterpreted hunger signals in the brain. Many developed insulin resistance, prediabetes, or diabetes symptoms.<\/p>\n

Simply put: COVID-19 induced a “regulatory confusion” in the body. It couldn\u2019t discern hunger from satiety, activity from fatigue, or health from illness.<\/p>\n

Hidden Post-Recovery Metabolic Syndrome: Silent and Slow Diseases<\/strong><\/p>\n

Metabolic syndrome encompasses high blood pressure, increased abdominal fat, elevated blood sugar, and lipid disorders. Previously common in sedentary individuals with poor diets, post-COVID even lean, healthy people showed signs of this syndrome.<\/p>\n

Studies found many recovered patients with elevated CRP (inflammation marker), HbA1c (long-term blood sugar indicator), and other inflammatory markers\u2014despite feeling well. This demands a redefinition of post-COVID health: apparently healthy does not equal truly healthy.<\/p>\n

Reprogrammed Body: How COVID Rewrote Our Biological Codes<\/strong><\/p>\n

COVID-19 did more than temporarily damage systems; it reprogrammed bodies. Scientifically, stable changes in cellular mechanisms, metabolic pathways, and intracellular signaling indicate the body’s “biological code” has been rewritten\u2014like software altered by a virus, not just broken but fundamentally changed.<\/p>\n

Research shows COVID altered gene expression regulation in some stem cells and modified insulin responses, fat storage, and ATP (cellular energy) production. This means some patients\u2019 bodies remain altered post-infection: more obese, less energetic, more anxious, and resistant to previous medications.<\/p>\n

Post-COVID Bodies Demand Treatments Aligned with Cellular Reprogramming<\/strong><\/p>\n

Traditional medicine is no longer sufficient. Post-COVID bodies need therapies compatible with these cellular rewrites, such as:<\/p>\n